Resveratrol Prevents EBV Transformation and Inhibits the Outgrowth of EBV-Immortalized Human B Cells

The Epstein-Barr Virus (EBV)-Induced Tumor Suppressor MicroRNA MiR-34a Is Growth Promoting in EBV-Infected B Cells

(2012) E. Forte et al.   JOURNAL OF VIROLOGY

Expression Profiling of Human Immune Cell Subsets Identifies miRNA-mRNA Regulatory Relationships Correlated with Cell Type Specific Expression

(2012) Florence Allantaz et al.   PLoS One

Chemosensitization of tumors by resveratrol

(2011) Subash C. Gupta et al.   Annals of the New York Academy of Sciences

Resveratrol and cellular mechanisms of cancer prevention

(2011) Yogeshwer Shukla et al.   Annals of the New York Academy of Sciences

Clinical trials of resveratrol

(2011) Ketan R. Patel et al.   Annals of the New York Academy of Sciences

Transport, stability, and biological activity of resveratrol

(2011) Dominique Delmas et al.   Annals of the New York Academy of Sciences

Immunotherapy for EBV-associated malignancies

(2011) Anna Merlo et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Epstein-Barr Virus Latent Membrane Protein 1 Induces Cancer Stem/Progenitor-Like Cells in Nasopharyngeal Epithelial Cell Lines

(2011) S. Kondo et al.   JOURNAL OF VIROLOGY

Resveratrol Inhibits Proliferation and Survival of Epstein Barr Virus-Infected Burkitt's Lymphoma Cells Depending on Viral Latency Program

(2011) A. De Leo et al.   MOLECULAR CANCER RESEARCH

Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation

(2010) David O Kennedy et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Antiviral activity of resveratrol: Table 1

(2010) Michela Campagna et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients

(2010) Nishitha Reddy et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

(2010) V. A. Brown et al.   CANCER RESEARCH

Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD

(2010) Esmerina Tili et al.   CARCINOGENESIS

Virally Induced Cellular MicroRNA miR-155 Plays a Key Role in B-Cell Immortalization by Epstein-Barr Virus

(2010) S. D. Linnstaedt et al.   JOURNAL OF VIROLOGY

Inhibitory Effects of Resveratrol on the Epstein-Barr Virus Lytic Cycle

(2010) Ching-Yi Yiu et al.   MOLECULES

NF-κB signaling modulation by EBV and KSHV

(2010) Deilson Elgui de Oliveira et al.   TRENDS IN MICROBIOLOGY

Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye

(2010) Meav-Lang J Lay et al.   Virology Journal

Post-transplant lymphoproliferative disorders following solid-organ transplantation

(2010) Anne H Blaes et al.   Expert Review of Hematology

EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines

(2009) S.-C. Tsai et al.   BLOOD

Early Events Associated with Infection of Epstein-Barr Virus Infection of Primary B-Cells

(2009) Sabyasachi Halder et al.   PLoS One

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

(2008) D. Pende et al.   BLOOD

Epstein–Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway

(2008) Graziana Gatto et al.   NUCLEIC ACIDS RESEARCH

Conditional Immortalization of Human B Cells by CD40 Ligation

(2008) Martina Wiesner et al.   PLoS One